chronic insomnia. Nonorganic insomnia
Conditions
Interventions
Intervention 1: In the first group of intervention, patients receive 3 drops of almond violet oil in each nostril every night before sleep for a duration of one month. Each drop contains 33 mg of the
Treatment - Drugs
Placebo
In the first group of intervention, patients receive 3 drops of almond violet oil in each nostril every night before sleep for a duration of one month. Each drop contains 33 mg of the drug.
In the placebo group, patients receive 3 drops of placebo in each nostril every night before sleep for a duration of one month.Each drop contains 33 mg of the placebo.
In the second group of intervention, patients receive 3 drops of sweet almond oil in each nostril every night before sleep for a duration of one month. Each drop contains 33 mg of the drug.
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Willingness to cooperate; Having the pre-defined conditions of insomnia according to DSM-V-TR; Suffering from insomnia for at least 3 months; Being between 18 and 60 years old; Lack of physical diseases such as lung diseases, allergic rhinitis, cardiovascular, infectious diseases, cancer; Lack of mental illnesses such as depression, substance and drug abuse; Lack of neurological diseases such as Parkinson's and Alzheimer's disease; lack of sleep disorders like sleep apnea; lack of using drug and non-drug treatments for insomnia. Exclusion criteria: Pregnant and lactating women; History of allergy to medicinal herbs; Side effects of drugs; Irregular use of medication or treatment discontinuation; unwillingness to continue cooperation for any reason.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sleep. Timepoint: Before the intervention and one month after intervention. Method of measurement: Pittsburgh questionnaire, Insomnia Severity Index questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects. Timepoint: The end of study. Method of measurement: Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZohre Feyzabadi
Faculty of Traditional and Complementary Medicine, Mashhad University of Medical Sciences
Outcome results
None listed